Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy

NCT ID: NCT05560581

Last Updated: 2025-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-07

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of this project is to improve waiting periods for specialised psychotherapy. We will apply a brief, smartphone-based self-efficacy training to patients with psychiatric disorders waiting for specialised psychotherapy. Additionally, we will use Ecological Momentary Assessment (EMA) to assess mood, social contacts, and other parameters daily. We will investigate whether the training can improve self-efficacy and related constructs and if it can help reduce stress and waitlist drop-outs during waiting periods. Additionally, we will investigate if the self-efficacy training has a positive effect on motivation and therapeutical relationship regarding the subsequent therapy.

After a screening for eligibility, participants will be randomly assigned to intervention and control group. At baseline, participants attend a laboratory session where they are assessed for current psychiatric disorders and further relevant psychological variables. They will then either participate in the digital self-efficacy training combined with EMA (intervention group) or in EMA only (control group). Both will be conducted via a smartphone app. Subsequently, participants will be asked to fill in post questionnaires at three different time points: after having finished app usage, one month later, and after the beginning of the subsequent psychotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psychiatric Disorder Waiting for Psychotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
double-blind

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Participants will receive an one-week digital self-efficacy training (3x/day) and an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).

Group Type EXPERIMENTAL

Digital self-efficacy training

Intervention Type BEHAVIORAL

Prior to the app participation, participants will receive psychoeducation on self-efficacy and will be instructed to define two autobiographical self-efficacy memories (own achievements, e.g., completion of an exam, success in a sporting event). During the week of app participation, they will be prompted three times per day and asked to perform an imagination task. Step by step, they will recall one of their autobiographic self-efficacy memories and focus on their character traits and abilities that were relevant for their achievement.

Ecological Momentary Assessment

Intervention Type BEHAVIORAL

Participants will receive questions on mood and social/virtual contacts 3 times per day.

Control group

Participants will receive an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).

Group Type ACTIVE_COMPARATOR

Ecological Momentary Assessment

Intervention Type BEHAVIORAL

Participants will receive questions on mood and social/virtual contacts 3 times per day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Digital self-efficacy training

Prior to the app participation, participants will receive psychoeducation on self-efficacy and will be instructed to define two autobiographical self-efficacy memories (own achievements, e.g., completion of an exam, success in a sporting event). During the week of app participation, they will be prompted three times per day and asked to perform an imagination task. Step by step, they will recall one of their autobiographic self-efficacy memories and focus on their character traits and abilities that were relevant for their achievement.

Intervention Type BEHAVIORAL

Ecological Momentary Assessment

Participants will receive questions on mood and social/virtual contacts 3 times per day.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* psychiatric disorder
* age 18-65
* waiting for psychiatric assessment/treatment (being on waitlist)
* sufficient knowledge of the German language
* smartphone user
* internet access via smartphone
* internet access at home (laptop, tablet, or computer)

Exclusion Criteria

* current intense psychotherapy
* acute suicidality
* acute psychotic symptoms
* substance addiction
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Psychiatric University Hospital, Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Judith Rohde, MD

Clinician Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Judith Rohde, MD

Role: PRINCIPAL_INVESTIGATOR

Psychiatric University Hospital Zurich, University of Zurich

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Integrated Psychiatry Winterthur

Winterthur, , Switzerland

Site Status RECRUITING

Psychiatric University Hospital

Zurich, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Judith Rohde, MD

Role: CONTACT

+41 (0)58 384 65 00

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jochen Binder

Role: primary

Judith Rohde

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SeApp III

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Recovery Therapy Trial
NCT00239122 COMPLETED NA